FDA approves HPV test as initial screen for cervical cancer

FDA approves HPV test as initial screen for cervical cancer

hpv patient

The U.S. Food and Drug Adminis-tration recently approved a human papillomavirus (HPV) check as a primary step in cervical cancer screening for women aged 25 and older.
HPV, a sexually transmitted virus, is assumed to cause the majority of cervical cancers. Certain strains, such as HPV 16 and 18 are most powerfully tied to these tumors. The virus conjointly causes genital warts in each men and women and certain head and neck cancers.
Women who have test positive for the 2 high-risk of HPV strains (16 and 18) would then be asked to undergo a colposcopy. This involves employing a device that enables a doctor to get a clear view of the vulva, vagina and cervix and take a sample for further testing. Women who don’t have HPV 16 or 18 but have different high-risk types of the virus would have a Pap test to see if a colposcopy is required.

Exercise could curtail COPD complications

Exercise may facilitate  reduce the risk of hospital re-admission in people with a progressive lung condition referred to as  chronic obstructive pulmonary disease (COPD), a new study published in the Annals of the American Thoracic Society finds.
COPD refers to a group of diseases, together emphysema and chronic bronchitis, that cause airflow blockage and breathing issues.

 

 

Share on Facebook3Digg thisShare on Google+0Tweet about this on TwitterPin on Pinterest0Share on LinkedIn0Buffer this pageShare on StumbleUpon0Share on Reddit0Email this to someoneShare on Tumblr0Flattr the author

Leave a Reply

Your email address will not be published. Required fields are marked *